Topics

Takeda Pharmaceutical Company Limited & Seattle Genetics, Inc. Company Profile

04:29 EDT 17th September 2019 | BioPortfolio


News Articles [1938 Associated News Articles listed on BioPortfolio]

Seattle Genetics To Receive $30 Mln Milestone Payment From Takeda

WASHINGTON (dpa-AFX) - Seattle Genetics, Inc. (SGEN) announced that its collaborator, Takeda Pharmaceutical Company Limited, received approval from the European Commission to extend the marketing ...

Seattle Genetics Achieves $30 Million Milestone Payment for European Commission Approval of ADCETRIS (Brentuximab Vedotin) in Frontline Hodgkin Lymphoma

Seattle Genetics, Inc. (Nasdaq:SGEN) today announced that its collaborator, Takeda Pharmaceutical Company Limited, received approval from the European Commission to extend the marketing authorizat...

DGAP-Adhoc: Takeda Pharmaceutical Company Limited: Takeda Reports Strong First Quarter FY2019 Results and Raises Guidance for the Full Year

DGAP-Ad-hoc: Takeda Pharmaceutical Company Limited / Key word(s): Quarter Results/Change in Forecast Takeda Pharmaceutical Company Limited: Takeda Reports Strong First Quarter FY2019 Results and R...

Chembio Diagnostics and Takeda Pharmaceutical to Collaborate

Chembio Diagnostics (NASDAQ:CEMI) has announced it has entered into an agreement with Shire Human Genetic Therapies, a subsidiary of Takeda Pharmaceutical Company (TYO:4502). As quoted in the press re...

Takeda gibt Leistungskennzahlen für das Geschäftsjahr 2019 bekannt - mit Ausrichtung auf Steigerung des Unternehmenswerts und Schwerpunkt auf eine erfolgreiche Integration

Takeda Pharmaceutical Company Limited (kurz "Takeda") (TOKYO: 4502 NYSE: TAK) gibt bekannt, dass der Takeda-Vorstand die Key Performance Indicators (KPI), die sowohl in die kurz- als auch in die l...

OrbiMed Comments on Takeda Pharmaceutical Company Limited Proxy Ahead of 143rd Ordinary General Meeting of Shareholders 2019

OrbiMed Advisors LLC (“OrbiMed”) has evaluated the proxy voting recommendations from both Institutional Shareholder Services Inc. (“ISS”) and the management of Takeda Phar...

Seattle Genetics reports positive data from enfortumab vedotin trial

Seattle Genetics and Astellas Pharma have announced positive topline results from a pivotal Phase II single-arm EV-201 clinical trial of...Read More... The post Seattle Genetics reports positive data ...

Chembio Diagnostics and Takeda Pharmaceutical Company Collaborate for Development of Point-of-Care Diagnostic Test

MEDFORD, N.Y., July 18, 2019 (GLOBE NEWSWIRE) — Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care (POC) diagnostics company focused on infectious diseases, today announced that i...

Drugs and Medications [435 Associated Drugs and Medications listed on BioPortfolio]

Nesina [takeda pharmaceuticals america, inc.]

These highlights do not include all the information needed to use NESINA safely and effectively. See full prescribing information for NESINA. NESINA (alogliptin) tablets, for oral use Initial U.S. App...

Oxygen [seattle children's hospital]

Oxygen

Chlorure de potassium proamp [laboratoire aguettant]

Potassium Chloride for Injection Concentrate, USP

Oxygen [lowry drug company inc. ]

Oxygen

Oxygen [island equipment company]

Oxygen

PubMed Articles [1012 Associated PubMed Articles listed on BioPortfolio]

Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan.

Clinical practice guidelines (CPGs) are important in advancing the quality of medical care. Financial relationships between physicians and pharmaceutical companies may influence clinical practice. In ...

Electrocardiogram interpretation in NCAA athletes: Comparison of the 'Seattle' and 'International' criteria.

Accurate electrocardiogram (ECG) interpretation in competitive athletes requires the distinction of physiological adaptations from findings suggestive of a pathological condition. The purpose of this ...

Validity of the Seattle Heart Failure Model after heart failure hospitalization.

Heart failure hospitalization is a sentinel event associated with increased mortality risk. Whether long-term heart failure risk models such as the Seattle Heart Failure Model (SHFM) accurately assess...

Harambee!: A pilot mixed methods study of integrated residential HIV testing among African-born individuals in the Seattle area.

African-born individuals in the U.S. are disproportionately affected by HIV yet have low HIV testing rates. We conducted a mixed methods study to assess the uptake and feasibility of a novel strategy ...

PharmaForum Takeda.

Clinical Trials [884 Associated Clinical Trials listed on BioPortfolio]

A Study to Compare the Bioavailability (BA) of Dexlansoprazole Delayed-release Capsules

The purpose of this study is to assess the BA of 30 or 60 milligram (mg) dexlansoprazole capsule manufactured at TOB (Takeda GmbH Plant Oranienburg) to the corresponding 30 or 60 mg dexlan...

Bioequivalence Study of Dexlansoprazole Capsules From Two Manufacturing Plants

The purpose of this study is to assess the bioavailability of dexlansoprazole from a 30 milligram (mg) or 60 mg delayed-release capsule manufactured at Takeda GmbH Plant Oranienburg, Germa...

Hereditary Angioedema Kininogen Assay

Hereditary angioedema (HAE) is a rare autosomal dominant genetic disorder characterized by recurrent tissue angioedema episodes, mainly caused by mutations in the SERPING1 gene that encode...

Impact of Non-Commercialism Policy in Seattle Schools

This pilot study on the impact of a non-commercialism policy in Seattle schools will assess and evaluate obesity-related health outcomes of a real-life policy decision, recently voted on a...

Genetics Education: Preparing Physicians for the Future

This study examines the best way to teach genetics to family medicine residents. First year family medicine residents at the University of Toronto will be taught basic clinical genetics as...

Companies [3372 Associated Companies listed on BioPortfolio]

Takeda Pharmaceutical Company Limited and Seattle Genetics, Inc.

Takeda Pharmaceutical Company Limited (TSE: 4502) is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to ...

Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited (TSE: 4502) is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to ...

Takeda Pharmaceuticals International, Inc.

Located in Deerfield, Illinois, Takeda Pharmaceuticals International, Inc. is a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, an industry leader and the larges...

Takeda San Francisco, Inc.

Takeda San Francisco, Inc. (TSF), established in November 2007 as a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Osaka, Japan, is Takeda's Biologics Center of Excellence and Antib...

Takeda Pharmaceutical Company Limited & Seattle Genetics, Inc.

More Information about "Takeda Pharmaceutical Company Limited & Seattle Genetics, Inc." on BioPortfolio

We have published hundreds of Takeda Pharmaceutical Company Limited & Seattle Genetics, Inc. news stories on BioPortfolio along with dozens of Takeda Pharmaceutical Company Limited & Seattle Genetics, Inc. Clinical Trials and PubMed Articles about Takeda Pharmaceutical Company Limited & Seattle Genetics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Takeda Pharmaceutical Company Limited & Seattle Genetics, Inc. Companies in our database. You can also find out about relevant Takeda Pharmaceutical Company Limited & Seattle Genetics, Inc. Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record